{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Pazopanib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Pazopanib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Pazopanib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "pazopanib",
    "trial_2_text": "Pazopanib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Pazopanib Supplement: 60 participants will take Pazopanib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Pazopanib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Pazopanib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "78": 0.6557486057281494,
      "87": 0.5206465125083923,
      "189": 0.32165876030921936,
      "188": 0.26701265573501587,
      "67": 0.22914910316467285,
      "228": 0.22161869704723358,
      "339": 0.21376454830169678,
      "20": 0.20847328007221222,
      "123": 0.2041434347629547,
      "17": 0.2036503255367279,
      "173": 0.20277489721775055,
      "46": 0.19969791173934937,
      "64": 0.19822221994400024,
      "2": 0.19401033222675323,
      "37": 0.17764607071876526,
      "257": 0.16378897428512573,
      "124": 0.157951220870018,
      "9": 0.151123508810997,
      "101": 0.1499127894639969,
      "49": 0.1480458825826645,
      "350": 0.14774666726589203,
      "68": 0.14472001791000366,
      "4": 0.13670650124549866,
      "191": 0.13617368042469025,
      "77": 0.13476049900054932,
      "21": 0.1327795684337616,
      "177": 0.12944068014621735,
      "200": 0.12255684286355972,
      "382": 0.11552795767784119,
      "114": 0.11188119649887085,
      "79": 0.10660915821790695,
      "337": 0.10650516301393509,
      "104": 0.10644277930259705,
      "193": 0.10597385466098785,
      "29": 0.10529986023902893,
      "130": 0.10356783866882324,
      "239": 0.10333313792943954,
      "18": 0.10265744477510452,
      "5": 0.10117989033460617,
      "147": 0.0990179032087326,
      "234": 0.09695305675268173,
      "396": 0.0957023948431015,
      "100": 0.09548895061016083,
      "151": 0.09364303201436996,
      "179": 0.09274991601705551,
      "38": 0.09238076210021973,
      "126": 0.0922989770770073,
      "194": 0.09186103194952011,
      "136": 0.09171746671199799,
      "122": 0.08944625407457352,
      "261": 0.08929061889648438,
      "72": 0.0892547219991684,
      "86": 0.08921793103218079,
      "33": 0.08637885004281998,
      "243": 0.08291035890579224,
      "139": 0.08218470215797424,
      "14": 0.07983359694480896,
      "288": 0.07978170365095139,
      "131": 0.07951686531305313,
      "85": 0.07871255278587341,
      "121": 0.07853627949953079,
      "180": 0.07766129821538925,
      "204": 0.0759752094745636,
      "28": 0.07531087845563889,
      "27": 0.07469914853572845,
      "116": 0.07427266985177994,
      "276": 0.07259462773799896,
      "61": 0.07259117066860199,
      "142": 0.07033372670412064,
      "347": 0.0682661309838295,
      "356": 0.06754612177610397,
      "76": 0.06739041209220886,
      "286": 0.06689804047346115,
      "31": 0.06675384193658829,
      "35": 0.06667952239513397,
      "144": 0.065250463783741,
      "30": 0.06504900008440018,
      "82": 0.06423864513635635,
      "292": 0.0636514350771904,
      "186": 0.06208954006433487,
      "249": 0.061937544494867325,
      "400": 0.06018190085887909,
      "355": 0.06001397967338562,
      "422": 0.05979200452566147,
      "1": 0.05967974662780762,
      "75": 0.05911128222942352,
      "83": 0.05893150344491005,
      "454": 0.058383457362651825,
      "212": 0.058001741766929626,
      "132": 0.05759060010313988,
      "253": 0.05682799592614174,
      "97": 0.05596866086125374,
      "269": 0.05563123896718025,
      "36": 0.05378593131899834,
      "218": 0.05327519774436951,
      "341": 0.0525108203291893,
      "102": 0.05208354815840721,
      "263": 0.05195533484220505,
      "96": 0.05083411931991577,
      "282": 0.050631508231163025
    },
    "trial_2_ae": {
      "78": 0.6557486057281494,
      "87": 0.5206465125083923,
      "189": 0.32165876030921936,
      "188": 0.26701265573501587,
      "67": 0.22914910316467285,
      "228": 0.22161869704723358,
      "339": 0.21376454830169678,
      "20": 0.20847328007221222,
      "123": 0.2041434347629547,
      "17": 0.2036503255367279,
      "173": 0.20277489721775055,
      "46": 0.19969791173934937,
      "64": 0.19822221994400024,
      "2": 0.19401033222675323,
      "37": 0.17764607071876526,
      "257": 0.16378897428512573,
      "124": 0.157951220870018,
      "9": 0.151123508810997,
      "101": 0.1499127894639969,
      "49": 0.1480458825826645,
      "350": 0.14774666726589203,
      "68": 0.14472001791000366,
      "4": 0.13670650124549866,
      "191": 0.13617368042469025,
      "77": 0.13476049900054932,
      "21": 0.1327795684337616,
      "177": 0.12944068014621735,
      "200": 0.12255684286355972,
      "382": 0.11552795767784119,
      "114": 0.11188119649887085,
      "79": 0.10660915821790695,
      "337": 0.10650516301393509,
      "104": 0.10644277930259705,
      "193": 0.10597385466098785,
      "29": 0.10529986023902893,
      "130": 0.10356783866882324,
      "239": 0.10333313792943954,
      "18": 0.10265744477510452,
      "5": 0.10117989033460617,
      "147": 0.0990179032087326,
      "234": 0.09695305675268173,
      "396": 0.0957023948431015,
      "100": 0.09548895061016083,
      "151": 0.09364303201436996,
      "179": 0.09274991601705551,
      "38": 0.09238076210021973,
      "126": 0.0922989770770073,
      "194": 0.09186103194952011,
      "136": 0.09171746671199799,
      "122": 0.08944625407457352,
      "261": 0.08929061889648438,
      "72": 0.0892547219991684,
      "86": 0.08921793103218079,
      "33": 0.08637885004281998,
      "243": 0.08291035890579224,
      "139": 0.08218470215797424,
      "14": 0.07983359694480896,
      "288": 0.07978170365095139,
      "131": 0.07951686531305313,
      "85": 0.07871255278587341,
      "121": 0.07853627949953079,
      "180": 0.07766129821538925,
      "204": 0.0759752094745636,
      "28": 0.07531087845563889,
      "27": 0.07469914853572845,
      "116": 0.07427266985177994,
      "276": 0.07259462773799896,
      "61": 0.07259117066860199,
      "142": 0.07033372670412064,
      "347": 0.0682661309838295,
      "356": 0.06754612177610397,
      "76": 0.06739041209220886,
      "286": 0.06689804047346115,
      "31": 0.06675384193658829,
      "35": 0.06667952239513397,
      "144": 0.065250463783741,
      "30": 0.06504900008440018,
      "82": 0.06423864513635635,
      "292": 0.0636514350771904,
      "186": 0.06208954006433487,
      "249": 0.061937544494867325,
      "400": 0.06018190085887909,
      "355": 0.06001397967338562,
      "422": 0.05979200452566147,
      "1": 0.05967974662780762,
      "75": 0.05911128222942352,
      "83": 0.05893150344491005,
      "454": 0.058383457362651825,
      "212": 0.058001741766929626,
      "132": 0.05759060010313988,
      "253": 0.05682799592614174,
      "97": 0.05596866086125374,
      "269": 0.05563123896718025,
      "36": 0.05378593131899834,
      "218": 0.05327519774436951,
      "341": 0.0525108203291893,
      "102": 0.05208354815840721,
      "263": 0.05195533484220505,
      "96": 0.05083411931991577,
      "282": 0.050631508231163025
    }
  },
  "safety": {
    "trial_1_safety": 0.3358544707298279,
    "trial_2_safety": 0.3358544707298279
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4768558740615845
  }
}